Valeur20202022202320242025TTMFlux de trésorerie liés aux activités d'investissement-1.17 M-19.33 M1.61 M37.36 M12.45 M3.73 MFlux de trésorerie liés aux activités de financement64.05 M900 K40.37 M3.51 M14.94 M20.67 MFlux de trésorerie disponible-25.9 M-19.09 M-38.01 M-48.94 M-32.93 M-31.85 M
Avita Medical, Inc. - Common Stock
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.